Comment on 'Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series' by Dajani et al.-The Authors' Reply
1 Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
2 Regional Advisory Unit for Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway.
3 European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, Oslo, Norway.
4 Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
5 Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
6 Clinical Surgery University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.
7 Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.
8 Cancer Clinic, St Olavs Hospital-Trondheim University Hospital, Trondheim, Norway.
9 Oslo University Sykehus, European Palliative Care Research Centre, Division for Cancer Medicine, Institute of Cancer Medicine, Medical Faculty, University of Oslo, Oslo, Norway.